Vance Terry
SEC CIK 1572282 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | Dir | 5,800 | — | $139.5K | 2 | 2023-03-16 | 2023-12-13 |
Most active insiders at ENTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| 2 | Or Yat Sun | CSO | — | $34.0K |
| 3 | Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| 4 | Luu Brendan | Chief Business Off | — | $19.8K |
| 5 | Trout Harry R. III | See Remarks | — | $13.0K |
| 6 | Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| 7 | Capps Kathleen S. | See Remarks | — | $7,486 |
| 8 | Kowalsky Matthew Paul | CLO | — | — |
Vance Terry made no open-market trades at ENTA in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-15 | 2023-12-13 | ENTA | ENANTA PHARMACEUTICALS INC | Vance Terry | Dir | S - Sale | $9.12 | -15.3K | 5,800 | -73% | -$139.5K | |
| D | 2023-03-17 | 2023-03-16 | ENTA | ENANTA PHARMACEUTICALS INC | Vance Terry | Dir | M - OptEx | $14.00 | +5,800 | 21.1K | +38% | +$81.2K |
Purchase Sale Sale after option exercise All abbreviations